Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × efaproxiral × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 3 Sarcoma 1 Breast 1

Conditions

Neoplasm Metastasis 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Trastuzumab 16 Radiosurgery 14 Capecitabine 12 Radiotherapy 9 Magnetic Resonance Spectroscopy 9 Lapatinib 9 trastuzumab deruxtecan 7 Temozolomide 6 tucatinib 4 pembrolizumab 4 paclitaxel-Angiopep-2 conjugate 4 eribulin 4 Specimen Handling 4 Methotrexate 4 Cisplatin 4 pyrotinib 3 Vinorelbine 3 Radiation 3 Paclitaxel 3 Fluorodeoxyglucose F18 3 sacituzumab govitecan 2 pertuzumab 2 palbociclib 2 neratinib 2 durvalumab 2 cediranib 2 cabazitaxel 2 abemaciclib 2 Sodium Chloride 2 Observation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00083304 2013-05-10

ENRICH

Spectrum Pharmaceuticals, Inc

Phase 3 Completed

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡